| scholarly article | Q13442814 |
| P50 | author | David J. Sugarbaker | Q23304357 |
| Mark Rubin | Q37375521 | ||
| Matthew Meyerson | Q47451221 | ||
| Pasi A Jänne | Q74766165 | ||
| Rameen Beroukhim | Q88043871 | ||
| Levi A Garraway | Q89916155 | ||
| Barbara A Weir | Q106967220 | ||
| P2093 | author name string | David Christiani | |
| Fei Chen | |||
| John Minna | |||
| Javad Beheshti | |||
| Ming Lin | |||
| William R Sellers | |||
| William G Richards | |||
| Cheng Li | |||
| Luc Girard | |||
| Thomas LaFramboise | |||
| Jeffrey C Lee | |||
| Katsuhiko Naoki | |||
| Xiaojun Zhao | |||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | single-nucleotide polymorphism | Q501128 |
| homozygosity | Q114049690 | ||
| P304 | page(s) | 5561-5570 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis | |
| P478 | volume | 65 |
| Q40251406 | "Lineage addiction" in human cancer: lessons from integrated genomics |
| Q38377260 | A bayesian analysis for identifying DNA copy number variations using a compound poisson process |
| Q34065944 | A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene. |
| Q37318482 | A computational procedure to identify significant overlap of differentially expressed and genomic imbalanced regions in cancer datasets |
| Q33403709 | A flexible rank-based framework for detecting copy number aberrations from array data |
| Q40243714 | A genomic analysis of adult T-cell leukemia |
| Q34345591 | A global view of the oncogenic landscape in nasopharyngeal carcinoma: an integrated analysis at the genetic and expression levels |
| Q40216522 | A hierarchical clustering method for estimating copy number variation |
| Q33513807 | A statistical change point model approach for the detection of DNA copy number variations in array CGH data |
| Q30573762 | A survey of copy-number variation detection tools based on high-throughput sequencing data. |
| Q39619712 | A therapeutic target for smoking-associated lung cancer |
| Q40042206 | Aberrant splicing of the PTPRD gene mimics microdeletions identified at this locus in neuroblastomas |
| Q53280611 | Accumulative copy number increase of MET drives tumor development and histological progression in a subset of ovarian clear-cell adenocarcinomas. |
| Q42081770 | Acquired resistance of non-small cell lung cancer cells to MET kinase inhibition is mediated by a switch to epidermal growth factor receptor dependency |
| Q24600031 | Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab |
| Q36344108 | Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer |
| Q53264472 | Advances in the preclinical testing of cancer therapeutic hypotheses. |
| Q30014827 | Advances in understanding cancer genomes through second-generation sequencing |
| Q34737360 | Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women |
| Q24811573 | Allele-specific amplification in cancer revealed by SNP array analysis |
| Q27851396 | Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer |
| Q53428679 | Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis. |
| Q24657188 | Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis |
| Q35964699 | Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers |
| Q33810574 | Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor |
| Q41837923 | Amplification of chromosome 8 genes in lung cancer |
| Q33613086 | An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models |
| Q33511862 | An optimization framework for unsupervised identification of rare copy number variation from SNP array data |
| Q35810461 | Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA |
| Q54487205 | Array CGH reveals genomic aberrations in human emphysema. |
| Q34059518 | Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors. |
| Q30014823 | Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma |
| Q25257750 | BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH) |
| Q25257143 | CARAT: a novel method for allelic detection of DNA copy number changes using high density oligonucleotide arrays |
| Q24655494 | CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa |
| Q40015369 | CRKL as a lung cancer oncogene and mediator of acquired resistance to EGFR inhibitors: is it all that it is cracked up to be? |
| Q24607064 | CaSNP: a database for interrogating copy number alterations of cancer genome from SNP array data |
| Q34076335 | Calling amplified haplotypes in next generation tumor sequence data |
| Q37503954 | Cell line modeling for systems medicine in cancers (review). |
| Q24649926 | Characterizing the cancer genome in lung adenocarcinoma |
| Q23916995 | Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains |
| Q57274907 | Common and Contrasting Genomic Profiles among the Major Human Lung Cancer Subtypes |
| Q37395335 | Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts |
| Q61906657 | Comparative genome-wide profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas |
| Q54572748 | Comparative genomic hybridization array analysis and real-time PCR reveals genomic copy number alteration for lung adenocarcinomas. |
| Q39852530 | Comparison of primary neuroblastoma tumors and derivative early-passage cell lines using genome-wide single nucleotide polymorphism array analysis. |
| Q38310758 | Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array |
| Q30443218 | Concurrent loss of heterozygosity and copy number analysis in adenoid cystic carcinoma by SNP genotyping arrays |
| Q38381518 | Copy number variation in archival melanoma biopsies versus benign melanocytic lesions. |
| Q28307763 | Copy-number variation and association studies of human disease |
| Q36585123 | Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies |
| Q39662081 | DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway |
| Q28395184 | DNA copy number gains in malignant pleural mesothelioma |
| Q42153300 | Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer. |
| Q46949366 | Deletion mapping in Xp21 for patients with complex glycerol kinase deficiency using SNP mapping arrays |
| Q36943634 | Detection of DNA copy number alterations in cancer by array comparative genomic hybridization |
| Q36614403 | Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. |
| Q38370754 | Differential roles of trans-phosphorylated EGFR, HER2, HER3, and RET as heterodimerisation partners of MET in lung cancer with MET amplification |
| Q33308258 | Direct inference of SNP heterozygosity rates and resolution of LOH detection |
| Q34152841 | Discovering tumor suppressor genes through genome-wide copy number analysis |
| Q39923417 | ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry |
| Q37324886 | Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors |
| Q39739616 | Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1alpha in non-small cell lung cancer cells |
| Q38309871 | FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancer. |
| Q24658237 | Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells |
| Q47932500 | Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer |
| Q47862007 | Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer |
| Q33890597 | Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition |
| Q37895306 | Fibroblast growth factors and their receptors in cancer |
| Q27851615 | Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. |
| Q37164581 | Gab2-mediated signaling promotes melanoma metastasis |
| Q59265273 | Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer |
| Q83818621 | Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient |
| Q36115735 | Genetic changes in squamous cell lung cancer: a review |
| Q42365255 | Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer |
| Q28385454 | Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma |
| Q36802303 | Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays |
| Q54416989 | Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the UnderlyingNF2Status |
| Q86103494 | Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva |
| Q28385032 | Genomic aberrations in lung adenocarcinoma in never smokers |
| Q35873554 | Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer |
| Q35036588 | Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status |
| Q53264465 | Genomic characterization of asymptomatic CT-detected lung cancers. |
| Q34095608 | Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia |
| Q35176964 | Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma |
| Q33644509 | HaplotypeCN: copy number haplotype inference with Hidden Markov Model and localized haplotype clustering |
| Q35762499 | Heat shock protein 90 inhibition in lung cancer |
| Q39611034 | High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. |
| Q81000531 | High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss |
| Q37072451 | High-resolution mapping of copy-number alterations with massively parallel sequencing |
| Q36288148 | High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications |
| Q33997732 | Highly parallel genomic assays |
| Q37068513 | Highly parallel identification of essential genes in cancer cells |
| Q50465588 | Highly sensitive EGFR mutation detection by specific amplification of mutant alleles. |
| Q40098447 | Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution |
| Q37575617 | How is gene-expression profiling going to challenge the future management of lung cancer? |
| Q38320756 | Human genetics of diabetic nephropathy |
| Q38247113 | Human genetics of diabetic retinopathy |
| Q27000709 | Human genetics of diabetic vascular complications |
| Q35896530 | Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation? |
| Q27851654 | Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer |
| Q28080281 | Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention |
| Q24649562 | Integrated analysis of homozygous deletions, focal amplifications, and sequence alterations in breast and colorectal cancers |
| Q28396741 | Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old |
| Q38322114 | Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer |
| Q33644421 | Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma |
| Q37216672 | Integrative genomic approaches to understanding cancer. |
| Q39134067 | Inter-cellular adhesion disruption and the RAS/RAF and beta-catenin signalling in lung cancer progression |
| Q33244431 | Interrogation of genomes by molecular copy-number counting (MCC). |
| Q36562316 | Isothiocyanatostilbenes as novel c-Met inhibitors |
| Q37377962 | Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome |
| Q44292546 | Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma |
| Q28253671 | Lineage dependency and lineage-survival oncogenes in human cancer |
| Q27853197 | Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer |
| Q24646295 | MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib |
| Q36949256 | MET expression and amplification in patients with localized gastric cancer |
| Q37321772 | MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients. |
| Q38008247 | MET: a promising anticancer therapeutic target |
| Q33329722 | Major copy proportion analysis of tumor samples using SNP arrays |
| Q38421399 | Malignant tumors and forensics--dilemmas and proposals |
| Q31044207 | Mapping tumor-suppressor genes with multipoint statistics from copy-number-variation data |
| Q37416083 | Met amplification and tumor progression in Cdkn2a-deficient melanocytes |
| Q39911616 | Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer |
| Q52617931 | Metastatic cutaneous squamous cell carcinoma shows frequent deletion in the protein tyrosine phosphatase receptor Type D gene. |
| Q33494538 | MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. |
| Q33691330 | MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma |
| Q34944632 | Microarray MAPH: accurate array-based detection of relative copy number in genomic DNA. |
| Q35127245 | Microarray-based ultra-high resolution discovery of genomic deletion mutations |
| Q40219823 | Molecular and genomic studies of IMMP2L and mutation screening in autism and Tourette syndrome |
| Q24610335 | Molecular biology of lung cancer: clinical implications |
| Q37427373 | Multiple genes in the 15q13-q14 chromosomal region are associated with schizophrenia |
| Q36036336 | Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability |
| Q42271046 | New lung cancer panel for high-throughput targeted resequencing |
| Q38193571 | Nintedanib for the treatment of non-small-cell lung cancer |
| Q35672190 | Novel VPS13B Mutations in Three Large Pakistani Cohen Syndrome Families Suggests a Baloch Variant with Autistic-Like Features |
| Q35902144 | Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells |
| Q24678477 | Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer |
| Q35368205 | Our changing view of the genomic landscape of cancer |
| Q33520624 | Power to detect selective allelic amplification in genome-wide scans of tumor data |
| Q37398814 | Protein arginine methyltransferase 5 is essential for growth of lung cancer cells |
| Q36092374 | Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase A oncogene. |
| Q37094061 | Protein tyrosine phosphatases: functional inferences from mouse models and human diseases. |
| Q29048634 | Psychomotor retardation with a 1q42.11–q42.12 deletion |
| Q31104515 | QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data |
| Q27851896 | Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors. |
| Q38260826 | Receptor-type protein tyrosine phosphatases in cancer |
| Q43095950 | Reconstruction of an integrated genome-scale co-expression network reveals key modules involved in lung adenocarcinoma |
| Q33472669 | Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer |
| Q34550261 | Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma |
| Q36448676 | Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer |
| Q33271882 | Resolving the resolution of array CGH. |
| Q28741003 | Role of protein tyrosine phosphatases in cancer |
| Q33267748 | SIGMA: a system for integrative genomic microarray analysis of cancer genomes |
| Q36633219 | SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines |
| Q33316565 | SNPExpress: integrated visualization of genome-wide genotypes, copy numbers and gene expression levels |
| Q37273694 | Single nucleotide polymorphism arrays: a decade of biological, computational and technological advances |
| Q37287242 | Smoking-related genomic signatures in non-small cell lung cancer |
| Q24648102 | Somatic mutations affect key pathways in lung adenocarcinoma |
| Q35008652 | SubPatCNV: approximate subspace pattern mining for mapping copy-number variations |
| Q35370365 | TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer |
| Q38690050 | Targeting FGFR in Squamous Cell Carcinoma of the Lung |
| Q34309927 | Targeting MET Amplification as a New Oncogenic Driver. |
| Q24653582 | The application of single nucleotide polymorphism microarrays in cancer research |
| Q51954143 | The common inversion of the Williams-Beuren syndrome region at 7q11.23 does not cause clinical symptoms. |
| Q34129229 | The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence |
| Q21090194 | The diploid genome sequence of an individual human |
| Q40169126 | The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272. |
| Q52316580 | The multiple paths towards MET receptor addiction in cancer. |
| Q46642951 | The polymorphisms of protein-tyrosine phosphatase receptor-type delta gene and its association with pediatric asthma in the Taiwanese population |
| Q36445020 | The progress on genetic analysis of nasopharyngeal carcinoma |
| Q34274069 | The target therapy of ovarian clear cell carcinoma |
| Q28115840 | The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers |
| Q38956071 | Tivantinib (ARQ 197) efficacy is independent of MET inhibition in non-small-cell lung cancer cell lines |
| Q38089070 | Use of SNPs in cancer predisposition analysis, diagnosis and prognosis: tools and prospects. |
| Q37649231 | YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway. |
| Q54566385 | [Modified Restriction Enzyme-based Detection of EGFR Mutations in Lung Cancer]. |
| Q35199181 | c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases |
| Q34597425 | siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors |
Search more.